Cargando…
Resistance of melanoma cells to anticancer treatment: a role of vascular endothelial growth factor
Melanoma is one of the most aggressive and resistant to treatment neoplasms. There are still many challenges despite many promising advances in anticancer treatment. Currently, the main problem for all types of treatment is associated with heterogeneity. Due to heterogeneity of cancer cells, “precis...
Autores principales: | Bogusławska-Duch, Joanna, Ducher, Magdalena, Małecki, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247075/ https://www.ncbi.nlm.nih.gov/pubmed/32467677 http://dx.doi.org/10.5114/ada.2020.93378 |
Ejemplares similares
-
Therapeutic combination silencing VEGF and SOX10 increases the antiangiogenic effect in the mouse melanoma model B16-F10 – in vitro and in vivo studies
por: Bogusławska-Duch, Joanna, et al.
Publicado: (2021) -
Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
por: Salven, P., et al.
Publicado: (1997) -
Vascular endothelial growth factor‐C in activating vascular endothelial growth factor receptor‐3 and chemokine receptor‐4 in melanoma adhesion
por: Hlophe, Yvette N., et al.
Publicado: (2022) -
The role of vascular endothelial growth factor in ossification
por: Yang, Yan-Qi, et al.
Publicado: (2012) -
Efficacy of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular Degeneration and Systemic Cardiovascular Risk Factors
por: Łądkowska, Joanna, et al.
Publicado: (2021)